A local woman who transformed her health, beat late onset asthma and went from breathless to full of energy is now helping others do the same at a Slimming World group in Inverleith. Did you know with ...

GSK beat profit expectations in the fourth quarter, driven by demand for its HIV drugs and Asthma medicine.

Regeneron (REGN) stock in focus as the company posts Q4 2025 beat as its revenue tied to Sanofi (SNY) partnership offsets headwinds to Eylea franchise. Read more here.

REGN's Q4 report could hinge on Dupixent profit growth and strong Eylea HD uptake as legacy Eylea sales face competitive ...

Can Baltimore beat heroin with $580M?

Cedar pollen levels dropped after sleet hit Austin, but cedar fever allergy season isn't over. See what to expect next and ...

Kymera Therapeutics KYMR announced that it has begun dosing patients in the phase IIb BREADTH study of KT-621 for moderate-to ...

GSK ( GSK) shares clocked seven straight sessions of gains, as the stock rose 1.7% at $60.19 on Friday. The multinational healthcare giant gained 16.8% in the preceding six sessions. The stock has ...

AZN gears up for Q4 results as cancer, diabetes and rare disease drugs drive sales expectations ahead of the Feb. 10 earnings ...

After forcing him to sign a document related to their divorce, deputies say they threatened to "have someone come over here and kill you" should he call the police.

Signs that Amgen was cooling on rocatinlimab emerged last year. Asked about the market positioning of the antibody at a Citi ...

Amgen AMGN reported fourth-quarter 2025 adjusted earnings of $5.29 per share, which beat the Zacks Consensus Estimate of ...